Martingale Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.03M | Buy |
|
|||||
|
2025
Q2 | $1.54M | Buy |
|
|||||
|
2025
Q1 | $807K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $261K | Hold |
|
|||||
|
2023
Q1 | $266K | Sell |
|
|||||
|
2022
Q4 | $1.39M | Buy |
|
|||||
|
2022
Q3 | $1.77M | Buy |
|
|||||
|
2022
Q2 | $1.73M | Buy |
|
|||||
|
2022
Q1 | $2.25M | Buy |
|
|||||
|
2021
Q4 | $1.62M | Hold |
|
|||||
|
2021
Q3 | $1.51M | Buy |
|
|||||
|
2021
Q2 | $425K | Hold |
|
|||||
|
2021
Q1 | $491K | Sell |
|
|||||
|
2020
Q4 | $515K | Sell |
|
|||||
|
2020
Q3 | $1.07M | Sell |
|
|||||
|
2020
Q2 | $1.43M | Hold |
|
|||||
|
2020
Q1 | $913K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $1.13M | Sell |
|
|||||
|
2018
Q4 | $1.3M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $205K | Sell |
|
|||||
|
2014
Q4 | $213K | Sell |
|
|||||
|
2014
Q3 | $796K | Buy |
|